A clinically relevant dose of CoQ10 reversed liver fibrosis via downregulation of ROS, inflammation, and hyperinsulinemia and upregulation of the Nrf2/ARE antioxidant pathway. Here, NFE2L2 is linked to hyperinsulinism.